Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Deliu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Comparative Effectiveness Research|March 7, 2019
Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?Francesco Sparano, Neil K Aaronson, Francesco Cottone, et al.
Trials|October 15, 2024
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2Nina Deliu, Rajenki Das, Angelique May, et al.
Proceedings of the ... AAAI Conference on Artificial Intelligence. AAAI Conference on Artificial Intelligence|April 26, 2024
Using Adaptive Bandit Experiments to Increase and Investigate Engagement in Mental HealthHarsh Kumar, Tong Li, Jiakai Shi, et al.
Science Translational Medicine|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertensionRowena J Jones, Eckart M D D De Bie, Nina Deliu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Comparative Effectiveness Research|March 7, 2019
Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes?Francesco Sparano, Neil K Aaronson, Francesco Cottone, et al.
Trials|October 15, 2024
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2Nina Deliu, Rajenki Das, Angelique May, et al.
Proceedings of the ... AAAI Conference on Artificial Intelligence. AAAI Conference on Artificial Intelligence|April 26, 2024
Using Adaptive Bandit Experiments to Increase and Investigate Engagement in Mental HealthHarsh Kumar, Tong Li, Jiakai Shi, et al.
Science Translational Medicine|May 20, 2026
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertensionRowena J Jones, Eckart M D D De Bie, Nina Deliu, et al.
Pageof 2